From AI-powered drug discovery to brain-computer interfaces and bioprinting, technology is rapidly reshaping how long, and how well we live. With the global healthcare market on track to reach about US $22.3 trillion by 2033, investment is flooding in, but access and equity lag behind. Who gets to be the “augmented human”? Where do the most cutting-edge breakthroughs go, and can AI and tech close the healthcare gap? As medicine becomes more automated and data-driven, other questions multiply: how do we protect data privacy, ensure regulation keeps pace with innovation, and preserve the human touch in a field built on individual care? Explore the frontier where science, data and ethics collide, asking not just whether we can extend life, but whether we can make it worth extending.